Document |
Document Title |
WO/2018/049836A1 |
A polymorph III of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[4-(2-methy
lpropoxy)phenylmethyl]urea tartrate, a preparation method therefor, and a medicinal use. Compared to the existing crystalline forms, the new crystalline form...
|
WO/2018/051115A1 |
A process for the production of glycolic acid or a derivative thereof comprises: reacting formaldehyde with carbon monoxide and water in a carbonylation reactor in the presence of a sulfurcatalyst, said reactor operating under suitable c...
|
WO/2018/049216A1 |
Monomeric bimetal hydroxycitric acid (HCA) compounds are provided. The subject compounds include a divalent metal (X) bonded to the carboxylic acids of C2 and C3 and a monovalent metal (Y) bonded to the carboxylic acid of C1. Also provid...
|
WO/2018/049383A1 |
Disclosed herein are compositions and methods for treating nervous system injury in a subject.
|
WO/2018/042265A1 |
An inkjet ink composition comprising: one or more UV curable monomers; oligomers having one or more acrylic groups; one or more photoinitiators; one or more surfactants; and paraffin wax.
|
WO/2018/039390A1 |
Disclosed are compounds having a monoterpenoid and/or phenylpropanoid moiety and methods of their making and use as pesticidal compounds, such as herbicides.
|
WO/2018/025892A1 |
The purpose of the present invention is to provide a novel polymerizable triptycene derivative compound, which has a structure in which three benzene rings arranged around barrelene having a triptycene skeleton are capable of balanced ro...
|
WO/2018/019549A1 |
The invention discloses 2-((2R,4R)-4-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)-2-(tert-
butyl)-5-oxo-1,3-dioxolan-4-yl)acetic acid of formula (XIX), a process for its preparation and processes for its conversion into enantiomerically pure (...
|
WO/2018/018151A1 |
The description relates to, inter alia, recombinant microorganisms, engineered metabolic pathways, chemical catalysts, and products produced through the use of the described methods and materials. The products produced include methylenem...
|
WO/2018/012847A1 |
The present invention provides an integrated system comprising: an electrocatalysis device for producing hydrogen by carrying out an oxidation reaction at an anode and a reduction reaction at a cathode through an electrocatalysis of glyc...
|
WO/2018/011741A1 |
Disclosed are methods for preparing a levulinic acid mixture in a reaction vessel that is, for example, suitable for use in synthesizing a glyceryl ketal of levulinic acid or an ester of levulinic acid comprising distilling a combination...
|
WO/2018/010932A1 |
The present invention relates to a method of reacting starting materials with an activating group, namely alkanes carrying a leaving group and/or olefins, with carbon dioxide under transition metal catalysis to give carboxyl group-contai...
|
WO/2018/001861A1 |
The invention relates to a method for producing 2-methoxyacetic acid by oxidizing 2-methoxyethanol in a reaction device using oxygen at a temperature of 20 to 100 °C and at an oxygen partial pressure of 0.01 to 2 MPa in the presence of ...
|
WO/2018/003569A1 |
Provided is a method for producing an unsaturated fatty acid oxide (e.g. ω3 fatty acid oxide) that is new and has more beneficial features compared to conventional technologies. This method uses a lipoxygenase-containing composition (e....
|
WO/2017/222043A1 |
The purpose of the present invention is to provide: a crystal of HMB amino acid salt, which is easy to handle and is highly soluble; and a production method of said crystal. According to the present invention, a crystal of HMB amino acid...
|
WO/2017/217333A1 |
To provide a method of producing a C2–C20 fluorine-containing organic acid having a reduced proportion of non-fluorine-containing organic compounds. A method of producing a C2–C20 fluorine-containing organic acid, the method includin...
|
WO/2017/210771A1 |
The present disclosure relates to bisphenol ether derivatives and compositions thereof, which can be useful in radiation therapy for treatment of diseases, such as prostate cancer. In particular, the compounds of the present disclosure c...
|
WO/2017/206468A1 |
The present invention relates to a technique for mild oxidation of lignite. Provided is a method using oxygen gas under standard pressure as an oxidant for catalytic oxidation of a lignite. The method uses oxygen gas as the oxidant for m...
|
WO/2017/205750A1 |
Provided herein are compositions and method for producing γ-polyglutamic acid (PGA). In particular, provided herein are bacterial co-culture systems and methods for producing PGA.
|
WO/2017/194700A1 |
The present invention concerns a method for purifying an aqueous lactic acid solution, obtained from a fermentation medium or from any other source previously cleared of solid substances and/or of biomass that may be present and ionic su...
|
WO/2017/191554A1 |
In the process of the present disclosure 3,6-dichloro-2-methoxybenzoic acid (DICAMBA) is prepared from 2,5-dichloroaniline in high purity and high yield. DICAMBA is obtained with purity greater than 98.5 %.
|
WO/2017/191483A1 |
A process for producing butanol is provided, involving: A) mixing water, lactate, an enzyme mixture comprising at least one enzyme, at least one cofactor and at least one coenzyme, to prepare a reaction mixture; B) catalytically reacting...
|
WO/2017/191282A1 |
The present invention regards new adipate-type compounds suitable as an intermediate in organic chemistry, a platform chemical for the production of other chemicals, and as a monomer and co-monomer useful for the preparation of polymers ...
|
WO/2017/182097A1 |
The present invention relates an improved and well reproducible process for the preparation of Enclomiphene citrate having needle shaped crystal habit, and moreover, it is also related to a solid form of Enclomiphene citrate.
|
WO/2017/175522A1 |
The present invention provides various oxa acids having different molecular weights and hydrophilic/lipophilic balance. In the present invention, a compound having a structure represented by formula (1) or formula (2) is used.
|
WO/2017/167705A1 |
A method for the manufacture of perfluorinated compounds is herein disclosed. In particular, the method is useful for the manufacture of perfluorooxyalkyl carboxylic acid salts which can be used as surfactants. The method envisages the f...
|
WO/2017/170549A1 |
The present invention relates to a method for efficiently producing high-quality hydroxycinnamic acids from a cellulose-containing biomass. More specifically, the present invention relates to a method for producing hydroxycinnamic acids,...
|
WO/2017/161452A1 |
This invention relates to a method for the conversion of lignocellulosic biomass into ethyl esters of carboxylic acids. Said method consists of treating the biomass material with an oxidizing agent that is incorporated in an solution com...
|
WO/2017/148357A1 |
The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate can be prepared by subjecting a compound to a deprotection reaction. The intermediate can be used as a raw material ...
|
WO/2017/149017A1 |
The invention discloses a method for the preparation of (3,4-dihydroxyphenyl)acetic acid or its ester starting from the respective nitrile, and the conversion of (3,4-dihydroxyphenyl)acetic acid ester to hydroxytyrosol.
|
WO/2017/147145A1 |
The disclosure provides for coating compositions comprising macrocycles and salts in aqueous buffer and the use of the coating composition to prevent absorption of small molecules into polymeric surfaces.
|
WO/2017/144885A1 |
Described herein is a supported catalyst for a liquid-phase reaction, the supported catalyst comprising a perovskite support comprising A-site species and B-site species and a catalytic component on a surface of the perovskite support. A...
|
WO/2017/147598A1 |
Methods for the treatment of Homozygous Familial Hypercholesterolemia by administering gemcabene as an adjunct to other lipid lowering therapy and/or modified diet.
|
WO/2017/143446A1 |
The disclosure provides compositions comprising tricarboxylic acid cycle intermediates and at least one anti-oxidant. In one embodiment, the composition comprises pyruvic acid, citric acid and malic acid in combination with the anti-oxid...
|
WO/2017/137955A1 |
The present invention relates to novel chiral 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylprop
an-1-amine (5) and racemic 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylprop
an-1-amine () and its use in improved and ...
|
WO/2017/134139A1 |
The present invention provides a method of preparing glycolic acid ( HOCH2COOH ), the method at least comprising the steps of: (a) providing an aqueous oxalic acid (HOOCCOOH) containing stream having a molar ratio of water/oxalic acid of...
|
WO/2017/131047A1 |
The presentt invention addresses the problem of providing a photocuring method that obtains a crosslinked product (resin) quickly and efficiently, a compound used in the photocuring method, and a photocurable resin composition containing...
|
WO/2017/125673A1 |
The invention relates to a method for preparing a compound (I) or one of the salts thereof, and the uses of said method, R1OOC-C(=X)-CHR2 R3 (I), wherein X is selected among O; N-R', wherein R' is H or a C1-C6 alkyl; and N-OR'' wherein R...
|
WO/2017/121887A1 |
A process for producing oxalic acid containing or having the following steps: i) Utilizing a chemical reaction to produce an alkali metal formate and/or alkaline earth metal formate; ii) Converting the alkali metal formate and/or alkalin...
|
WO/2017/117346A1 |
The present invention generally relates to fluids for metalworking and other applications and, in particular, to compounds useful in such fluids. For instance, some aspects of the invention are generally directed to molecular compounds c...
|
WO/2017/114456A1 |
The present invention provides a novel, pharmaceutically acceptable salt of a morpholine derivative, including malate salt, tartrate salt, hydrochloride salt, acetate salt and naphthalene diphosphate salt. The tartrate salt has three cry...
|
WO/2017/111994A1 |
Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues and hydroxybenzoic acid, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepare...
|
WO/2017/111179A1 |
The present invention provides a cocrystal of (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1
H-1,2,4-triazol-5(4H)-one and an organic acid capable of forming a cocrystal with the compound. Specific cocrystals prepared are c...
|
WO/2017/106974A1 |
Two isoforms of thyroid receptor alpha (THRα1 and THRα2) have been found to be associated with the growth of cancer. Use of inhibitors of THRα1 (Formula I) and/or agonists of THRα2 (Formula II) in the treatment of such cancers is dis...
|
WO/2017/104782A1 |
In order to provide a method for manufacturing a compound (1) or a pharmaceutically acceptable salt thereof, whereby yield can be improved, cost can be reduced by using an easily obtained, inexpensive starting material and efficiently re...
|
WO/2017/104880A1 |
The present invention provides a lactic acid bacterial strain having antibacterial activity for an antibacterial purpose, wherein lactobacillus plantarum IRWEE-01 produces high levels of various antibacterial, antifungal, and antiviral s...
|
WO/2017/102087A1 |
The present invention relates to a method for producing a polyol from an unsaturated fatty acid with one or more double bonds, or a polyol from a fatty acid derivative having at least one unsaturated fatty acid group with one or more dou...
|
WO/2017/104961A1 |
The present application relates to a series of preparation methods of extracting, separating and purifying, and commercializing ferulic acid, which is a highly functional material, from cornhusk, which is a by-product of grain and, more ...
|
WO/2017/097251A1 |
The present invention relates to two optically pure isomers called NK007 for short, synthesis thereof, and an application thereof in the protection against plant viruses and the regulation of immunological activity. Compounds NK007-1 and...
|
WO/2017/100213A1 |
The present invention relates to stabilization of one or more component of a PCR or RT-PCR reaction mixture at ambient temperatures. In particular, formulations, compositions, articles of manufacture, kits and methods for substantially s...
|